OGEN
Oragenics IncAMEX
Healthcare • Biotechnology
$0.35+0.04%
Close Nov 6, 2026
- Market cap
- $1.55M
- 1 month
- -24.6%
- 3 months
- -36.3%
- 1 year
- -69.4%
- 52-week range
- $0.35$1.16
- Dividend
- No dividends on record
- Short interest
- 18.9% of float837K shares · settled Oct 15, 2026 · -0.6% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$10.08M
- Free cash flow
- -$10.21M
- Book value
- $3.67M
- Total debt
- —
- P/E
- —
- Price / sales
- —
- Price / book
- 0.4×
- FCF yield
- -660.1%
- Net margin
- —
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Oragenics Inc
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States.
Read more
Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
- Website
- oragenics.com
- Headquarters
- Lakewood Ranch, FL, United States
- Employees
- 3
- Listed
- Feb 25, 2004
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 1, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 13, 2026 | — | — | — | -$2.6M | -$2.5M |
| Mar 2026filed May 8, 2026 | — | — | — | -$2.3M | -$2.2M |
| Dec 2025filed Mar 16, 2026 | — | — | — | -$2.5M | -$2.3M |
| Sep 2025filed Nov 7, 2025 | — | — | — | -$3.1M | -$3.1M |
| Jun 2025filed Aug 8, 2025 | — | — | — | -$1.7M | -$2.3M |
| Mar 2025filed May 9, 2025 | — | — | — | -$2.0M | -$2.2M |
| Dec 2024filed Mar 14, 2025 | $3.1M | — | 50.0% | -$3.4M | -$3.3M |
| Sep 2024filed Nov 13, 2024 | — | — | — | -$2.4M | -$2.5M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 16, 2026 | — | — | — | -$9.4M | -$9.8M |
| Dec 2024filed Mar 14, 2025 | — | — | — | -$10.6M | -$10.6M |
| Dec 2023filed Mar 29, 2024 | $37.7K | -71.4% | — | -$20.9M | -$20.7M |
| Dec 2022filed Apr 17, 2023 | $131.5K | +51.2% | 66.0% | -$14.4M | -$14.3M |
| Dec 2021filed Mar 24, 2022 | $87.0K | — | 52.6% | -$15.8M | -$15.7M |
| Dec 2020filed Mar 1, 2021 | — | — | — | -$26.6M | -$26.4M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched OGEN. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
836,995 shares short
-4,639 shares (-0.6%) vs Sep 30, 2026
18.9% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
841,634 shares short
+35,092 shares (+4.4%) vs Sep 15, 2026
19% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
806,542 shares short
+11,627 shares (+1.5%) vs Aug 31, 2026
18.2% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
794,915 shares short
+5,992 shares (+0.8%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
788,923 shares short
+7,829 shares (+1%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
781,094 shares short
-1,997 shares (-0.3%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind OGEN’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 30 · reverse split
Effective Jun 3, 2025
Each 30 pre-split shares become 1 post-split share.
Source: EODHD
1 for 60 · reverse split
Effective Jan 23, 2023
Each 60 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Jan 22, 2018
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective Sep 28, 2010
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if OGEN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
2 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Aug 14, 2026
Insider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
16 filers reported a long position in OGEN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
100%
of the 67.5K shares 13-F filers reported
Moves vs Q1 2026
2 added2 trimmed
2 new · 4 unchanged
Net shares held
-58.3%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | $13.8K · 23.7K shares | 23.7K | -63.6% |
| 2 | 25 LLC | $13.4K · 23.2K shares | 23.2K | New |
| 3 | JANE STREET GROUP, LLC | $7.4K · 12.8K shares | 12.8K | New |
| 4 | Tower Research Capital LLC (TRC) | $2.6K · 4.5K shares | 4.5K | Unchanged |
| 5 | St. Johns Investment Management Company, LLC | $1.1K · 1.9K shares | 1.9K | +862% |
| 6 | BlackRock, Inc. | $408 · 703 shares | 703 | Unchanged |
| 7 | UBS Group AG | $373 · 642 shares | 642 | -87.7% |
| 8 | WELLS FARGO & COMPANY/MN | $20 · 34 shares | 34 | Unchanged |
| 9 | HARBOUR INVESTMENTS, INC. | $20 · 34 shares | 34 | Unchanged |
| 10 | SBI Securities Co., Ltd. | $13 · 23 shares | 23 | +109.1% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inGet the Full Analysis for OGEN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.